
Dr. Bassil Akra
@dr_akra
Followers
207
Following
5
Media
1
Statuses
576
CEO AKRA TEAM GmbH
Bayern, Deutschland
Joined September 2016
Two full days of #EUMDR in Brussels. Thank you Bioevents - Sharing Biomed Knowledge for hosting this event to help professionals with basic MDR knowledge going back to the foundation of the regulation. It was a real workshop which was shaped with my help…
linkedin.com
Two full days of #EUMDR in Brussels. Thank you Bioevents - Sharing Biomed Knowledge for hosting this event to help professionals with basic MDR knowledge going back to the foundation of the regulat...
1
0
4
#Software #validation is key, not just medical devices but all kind of software must be validated to avoid such 🙈 messaging. Check my personal experience with boarding passes the last weeks. Compare boarding time with gate closure time. No comments 😅🤪?
0
0
2
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
549
655
4K
Check the new #NANDO Website Structure:
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
0
1
I missed it this time Oliver Bisazza, but I will be there next time. I just received positive feedback about it 👏 Good job as usual 😉
linkedin.com
I missed it this time Oliver Bisazza, but I will be there next time. I just received positive feedback about it 👏 Good job as usual 😉
0
0
1
Paul Piscoi shared updates from the CI Group during the MedTech Summit 2023 . Key ongoing activities:. MEDDEV on clinical evaluation is under update.Device specific guidances are under preparation .SSCP Guidance is under update. Manufacturers will upload…
0
0
1
Medical background and Statistical Competence are essential in planning, conducting and reporting of successful #Clinical investigation. Very helpful presentation by Shelley Jambresic at #MedTechSummit2023
0
0
1
Shaloo Sood Kuthiala, PhD from Straumann Group presenting in a simple manner the difference between Hazard, Hazardous Situation and Harm. Check this out!. #RiskManagement #FMEA #MDR
linkedin.com
Shaloo Sood Kuthiala, PhD from Straumann Group presenting in a simple manner the difference between Hazard, Hazardous Situation and Harm. Check this out! #RiskManagement #FMEA #MDR
0
0
1
Good real world experience summary by Wojciech Bobela on Post-Market clinical investigation. Full Annex XV Requirements Submission is required in #Poland - This is applicable for PMCFs which are in other member states exempted from NCA Approval. Also, F…
linkedin.com
Good real world experience summary by Wojciech Bobela on Post-Market clinical investigation. Full Annex XV Requirements Submission is required in #Poland - This is applicable for PMCFs which are in...
0
0
1
Bianca Lutters presenting on Clinical Investigation Planing to meet EU #MDR. Are sites interested in participation?. Are patient interested to participate?. Is it ethical? . Various questions that must be asked before deciding on the best method to achie…
linkedin.com
Bianca Lutters presenting on Clinical Investigation Planing to meet EU #MDR Are sites interested in participation? Are patient interested to participate? Is it ethical? Various questions that must be...
0
0
1
Very good recommendations from Shweta Agarwal, PhD and Nataliya Deych at the MedTech Summit 2023. Plan systematically.Request a voluntary scientific opinion if your device is falling under the scope of the expert panel .Ask for a structured conversation w…
0
0
1
Esther Valk from #Medtronic and Klaus Schichl from #Biotronik presenting on the Q&A from the #MDCG 2021-6 . Key message: be careful, the Union Market is still not harmonized. Therefore, it is good to make use of presubmission meetings with the responsible…
linkedin.com
Esther Valk from #Medtronic and Klaus Schichl from #Biotronik presenting on the Q&A from the #MDCG 2021-6 Key message: be careful, the Union Market is still not harmonized. Therefore, it is good to...
0
0
2
Nebojsa Serafimovic is sharing the regulator’s perspective during the #MedTech Summit in Brussels. Key information: .1. A new #MEDDEV on clinical evaluation (2.7/1 Rev. 5 or MDCG) is under preparation 🥳.2. In Q4/2024 Switch of national systems to a mand…
linkedin.com
Nebojsa Serafimovic is sharing the regulator’s perspective during the #MedTech Summit in Brussels. Key information: 1. A new #MEDDEV on clinical evaluation (2.7/1 Rev. 5 or MDCG) is under preparation...
0
0
1
#OMTEC 2023 . Looking forward to seeing you all in Chicago. Join us and learn more about the regulatory implications on orthopedic industry. Gregory Jacobson, @LeanRAQASystems, Matthias Fink, Balazs Bozsik and Dan Goldstein
0
0
0
Don´t miss this event, join us and learn more about the current interpretation in the EU!. #Heartvalve #CEMark #Notifiedbody #ISO
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
0
0
It is nice being in #Tokyo again, meeting previous TÜV SÜD - Healthcare & Medical Devices Colleagues and enjoying the good food which is typically presented by my good friend Dr. Andreas Stange (The Food Tester 😉). This post is extra for you my friend 😅
linkedin.com
It is nice being in #Tokyo again, meeting previous TÜV SÜD - Healthcare & Medical Devices Colleagues and enjoying the good food which is typically presented by my good friend Dr. Andreas Stange (The...
0
0
0
Don’t miss this event, we are looking forward to seeing you all online!!!
0
0
0
3rd Annual EU Post-Market #Clinical Evaluation Planning Conference in Paris. Two recommendations:. #PMCF is not a unidirectional method. Review and justify the validity of the method by considering the open questions to be addressed. Regulatory processes…
linkedin.com
3rd Annual EU Post-Market #Clinical Evaluation Planning Conference in Paris Two recommendations: #PMCF is not a unidirectional method. Review and justify the validity of the method by considering the...
0
0
0
Don´t miss our annual TEAM-PRRC Event, Register now!. I will be there :) and looking forward to seeing you in Strasbourg!!!. Elem AYNE, Anne Jury, Ronald Boumans and Jean-Louis DIVOUX
linkedin.com
Don´t miss our annual TEAM-PRRC Event, Register now! I will be there :) and looking forward to seeing you in Strasbourg!!! Elem AYNE, Anne Jury, Ronald Boumans and Jean-Louis DIVOUX
0
0
0